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Summary: 
Glucose is the key metabolic substrate for tissue energy production. In the perinatal period the 
mother supplies glucose to the foetus and for most of the gestational period the normal lower 
limit of foetal glucose concentration is around 3mmol/L. Just after birth, for the first few hours of 
life in a normal term neonate appropriate for gestational age, blood glucose levels can range 
between 1.4 to 6.2mmol/L but by about 72 hours of age fasting blood glucose levels reach 
normal infant, child and adult values (3.5-5.5mmol/L). Normal blood glucose levels are 
maintained within this narrow range by factors which control glucose production and glucose 
utilization. The key hormones which regulate glucose homeostasis include insulin, glucagon, 
adrenaline, nor-adrenaline, cortisol and growth hormone. Pathological states that affect either 
glucose production or utilization will lead to hypoglycaemia. Although hypoglycaemia is a 
common biochemical finding in children (especially in the newborn) it is not possible to define by 
a single (or a range of) blood glucose value/s. It can be defined as the concentration of glucose 
in the blood or plasma at which the individual demonstrates a unique response to the abnormal 
milieu caused by the inadequate delivery of glucose to a target organ (for example, the brain). 
Hypoglycaemia should therefore be considered as a continuum and the blood glucose 
concentration should be interpreted in the context of the clinical presentation, counter-regulatory 
hormonal responses and in relation to the intermediate metabolites.    
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Introduction 
Blood glucose is the most important substrate for energy production during the perinatal, 
neonatal and postnatal periods. Apart from the first few days of life, normal fasting blood 
glucose concentrations are kept within a narrow physiological range of 3.5-5.5mmol/L. 
Continuous blood glucose monitoring shows that blood glucose concentrations may “flicker” on 
either side of these two values (especially post meal) but then rapidly and spontaneously revert 
to within this normal range[1]. Fasting and post-prandial normal blood glucose levels are 
maintained within this narrow range by a complex interplay of hormones which control glucose 
production and glucose utilization. Glucose is produced in the liver by glycogenolysis 
(breakdown of stored glycogen) and gluconeogenesis (formation of glucose from non-
carbohydrate sources such as lactate, alanine and glycerol). Apart from the liver, there is now 
evidence to show that the kidney also plays an important role as a gluconeogenic organ[2].  The 
key hormones which regulate glucose homeostasis include insulin, glucagon, adrenaline, nor-
adrenaline, cortisol and growth hormone (GH). Insulin typically regulates glucose homeostasis 
in the post-prandial state whereas the other hormones control blood glucose levels during the 
fasting state. Glucagon and adrenaline are the main line of defense against hypoglycaemia 
whereas cortisol and GH have a permissive role in regulating blood glucose levels.         
 
During the perinatal period, the foetus is dependent on a continuous supply of glucose from the 
mother[3]. In a normal foetus there is no endogenous glucose production, however under 
conditions where there is reduced glucose supply, the foetus has the capability to generate 
glucose endogenously[4]. The rate at which the foetus undertakes glucose utilization and 
oxidation is determined by the maternal arterial blood glucose concentration[5].  
 
After birth, the continuous supply of glucose to the foetus is interrupted and for the first few 
hours after birth, there is a transitional phase of physiologically low normal blood glucose levels 
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(transitional neonatal hypoglycaemia) which normalize around 72 hours after birth. It is during 
these first few hours after birth that blood glucose concentrations show marked physiological 
variability and this represents a normal transition phase of glucose physiology.             
 
Any pathological states which affect glucose production or utilization will lead to hypoglycaemia. 
In the neonatal, infancy and childhood periods, the finding of biochemical hypoglycaemia is 
common. However, despite the commonality of hypoglycaemia, in our current state of 
knowledge about glucose physiology, it is not possible to define hypoglycaemia by a particular 
blood glucose value/s. The brain is the key organ for glucose utilization and there is no doubt 
that low blood glucose levels can lead to neuronal energy deficiency and hence lead to brain 
injury[6]. There are no evidence based studies that define a particular blood glucose which 
leads to irreparable brain damage.   
 
Having an understanding of the physiological and biochemical mechanisms that regulate normal 
blood glucose levels will help in the diagnostic approach to a child with hypoglycaemia. A low 
blood glucose level has to be interpreted in the context of the clinical scenario, the presence or 
absence of alternative substrates, the method used to measure blood glucose and in the 
neonatal period in relation to feeds. As hypoglycaemia is a common biochemical finding, making 
the correct diagnosis is extremely important as this will guide the clinician in patient 
management. Any child presenting with unexplained hypoglycaemia will need a full biochemical 
diagnostic work up searching for the underlying cause of the hypoglycaemia.  
 
The aims of this review are to highlight the difficulty in defining hypoglycaemia, to describe the 
physiological and biochemical mechanisms that regulate blood glucose levels during the 
perinatal, neonatal and infancy periods and to review what “normal” blood glucose levels are 
during these periods.     
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Why is it difficult to define hypoglycaemia?   
Hypoglycaemia cannot be defined by a particular blood glucose value especially in the newborn 
period. The majority of appropriate for age term newborns show transient low blood glucose 
concentrations (transitional neonatal hypoglycaemia, discussed below) and this is a normal 
physiological adaptation process. Several different approaches have been used to define 
hypoglycaemia but none of these are satisfactory[7]. A single low blood glucose value cannot be 
applied universally to every individual patient.   
 
In the newborn and infancy periods, hypoglycaemia cannot be defined by the onset of signs and 
symptoms as these tend to be non-specific and are not easy to recognize in this age group 
(unlike older children and adults). Hypoglycemic symptoms vary from being nonspecific, such as 
poor feeding, lethargy, and irritability, to more severe ones, like apnea, seizures, or coma. 
Hence, the relevance of a careful detailed clinical assessment is of the utmost importance. The 
responses of the brain to hypoglycaemia (neuroglycopaenic symptoms arise when insufficient 
glucose is available to fuel the brain) occur over a range of blood glucose levels and these 
responses can be modified by previous episodes (antecedent) of hypoglycaemia and by the 
presence of alternative brain fuels (like ketone bodies and lactate). It is not possible to define a 
single blood glucose value which leads to brain damage as this will depend on the frequency, 
severity and duration of hypoglycaemia.    
 
In adults, clinical hypoglycaemia is defined as a blood glucose level which is low enough to 
cause symptoms and signs of impaired brain function[8]. Guidelines in adults emphasize the 
value of Whipple's triad for confirming hypoglycemia i.e., symptoms and/or signs consistent with 
hypoglycaemia, a documented low blood glucose concentration, and relief of signs/symptoms 
when blood glucose concentration is restored to normal. The same approach has been 
recommended for older children who are able to describe their symptoms [9]. However, this 
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cannot be applied to the younger infants and of course neonates, as they cannot convey their 
symptoms. 
 
When interpreting a blood glucose result, the method of collection of the blood sample will be 
important as some methods (especially bed side test strips) may be inaccurate.  Whole blood 
glucose values are about 15% less compared to those in the serum and plasma.  On the other 
hand, venous blood glucose concentrations are 10% lower than arterial.  For measurement of 
blood glucose, blood samples should be collected into fluoride containing tubes to inhibit 
glycolysis.          
 
Significant hypoglycaemia is not and can never be defined by a single number that can be 
applied universally to every individual patient. Rather, it is characterized by a value(s) that is 
unique to each individual and varies with both their state of physiologic maturity and the 
influence of pathology. It can be defined as the concentration of glucose in the blood or plasma 
at which the individual demonstrates a unique response to the abnormal milieu caused by the 
inadequate delivery of glucose to a target organ (for example, the brain). The “unique” response 
refers to the biochemical changes which are activated then the blood glucose level is lowered 
with/without the accompanying clinical manifestations. This response will be modulated by the 
availability of alternative fuels, the counter-regulatory hormonal responses and any episodes of 
antecedent hypoglycaemia. Thus, it is not possible to define a blood glucose level that requires 
intervention in every newborn infant because there is uncertainty over the level and duration of 
hypoglycaemia that can cause brain damage, and little is known of the vulnerability, or lack of it, 
of the brain of infants at different gestational ages for such damage. It is therefore clear that 
hypoglycaemia is a continuum and the blood glucose concentration should be interpreted in the 
context of the clinical presentation, counter-regulatory hormonal responses, in relation to feeds 
and in relation to the intermediate metabolites (fatty acids and ketone bodies). Thus, the blood 
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glucose concentration has to be interpreted in the context of the clinical scenario and the 
presence of alternative fuels.      
Perinatal glucose physiology 
The mother supplies glucose to the placenta and foetus with the placenta acting as a barrier 
regulating the transfer of nutrients and glucose to the foetus. For placental glucose to be 
transported to the foetus from the maternal circulation there has to be a net maternal-to-foetal 
plasma glucose concentration gradient that is determined by placental as well as the foetal 
glucose consumption[5].  Glucose is transferred to the placenta where it is partitioned between 
glucose consumption by the placenta and that transferred to the foetus.  
 
Glucose is taken up from the maternal plasma by the GLUT 1 transporter protein and 
transported to the foetus by facilitative diffusion according to concentration-dependent 
kinetics[10]. GLUT 1 is the main glucose transporter protein isoform in maternal-facing 
microvillus and foetal-facing syncytiotrophoblast membranes. The increase in the surface area 
and the maintenance of a high GLUT 1 density accounts for the increase in placental glucose 
transport in the latter part of pregnancy[11]. Studies in sheep have shown that in the second half 
of pregnancy, foetal glucose demand grows much more rapidly (about a 10 fold increase) than 
placental glucose transfer capacity and this then requires a decrease in foetal glucose 
concentration to balance glucose supply and demand[12]. The increased glucose transport 
leads to significant deposition of glycogen and fat stores, especially in the third trimester.   
 
Blood glucose values in the normal foetus 
The foetus consumes glucose as its principle metabolic fuel for energy production. The foetal 
glucose concentration is a function of both gestational age and the maternal glucose 
concentration. At around 20 weeks of gestational age there is a linear relationship between 
maternal and foetal glucose concentrations[13].  For most of the gestational period (and 
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especially after 20 weeks) the foetus is exposed to circulating glucose concentrations only 
slightly below those of maternal plasma. With a normal maternal glucose concentration of 3.5-
5.5mmol/L, the mean foetal-maternal plasma glucose difference at term is only 0.5mmol/L, thus 
in the term healthy foetus the normal glucose concentration is around 3mmol/L[3]. 
Glucose contributes nearly to 80% of the total energy requirement of the foetus and the 
remaining 20% of foetal energy needs is provided by lactate, amino acids and glycerol[14].  The 
foetus utilizes glucose at a higher rate than that observed in adults (5-7 mg/kg/min vs 2-
3mg/kg/min). Under normal conditions there is no foetal glucose production (by glycogenolysis 
or gluconeogenesis), but glucose production is stimulated in the foetus exposed to prolonged 
periods of low glucose supply (for example during fasting or placental insufficiency). Glycogenic 
enzymes are present in foetal liver as early as 8 weeks of gestation and the hepatic glycogen 
content increases from 3.4mg/g at 8 weeks of gestation to 50mg/g at term.  
 
Insulin is the main anabolic hormone in foetal life and islet pancreatic beta-cells can be detected 
in the pancreas as early as 10-12th weeks of gestation[15].  Foetal pancreatic beta-cells release 
insulin poorly in response to changes in the blood glucose concentration and the response to a 
glucose load is blunted. Insulin becomes detectable around 10-12 weeks of gestation in the 
foetus and during the perinatal period insulin is more important for regulating growth rather than 
regulating glucose metabolism.  
 
Glucose physiology in the normal term neonate: making the transition to an 
independent existence   
At birth the healthy term newborn must adapt to an independent existence. The transplacental 
supply of nutrients including glucose is interrupted and the newborn must now initiate metabolic 
and endocrine responses to maintain adequate circulating blood glucose concentrations. For 
extrauterine adaptation there must be adequate glycogen stores, intact and functional 
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glycogenolytic, gluconeogenic, lipogenic and ketogenic mechanisms and appropriate counter-
regulatory hormonal responses. Figure 1 shows the metabolic, endocrine and physiological 
changes which occur at the time of birth to allow a normal term newborn to adapt to an 
independent existence.       
 
An appropriate for gestational age normal infant shows an immediate postnatal fall 
(physiologically normal) in blood glucose concentrations during the first 2-4 hours of life. During 
this transitional phase, “normal” blood glucose values can range from as low as 1.4mmol/L to as 
high as 6.2mmol/L[16, 17]. The lowest mean blood glucose documented within the first few 
hours of birth can be as low as 2.3mmol/L[18]. Studies that have documented “normal” blood 
glucose concentrations in healthy, appropriate for gestational age newborns in the first hours of 
life are listed in table 1 [16 - 23].  
 
Healthy term breastfed babies have significantly lower blood glucose concentrations (mean 
3.6mmol/l; range 1.5–5.3), than those who are bottle-fed (mean 4.0mmol/l; range 2.5–6.2), but 
their ketone body concentrations are elevated in response to breast feeding[17, 23]. Figure 2 
shows the results of a study [23] with the serial mean and +/-SD plasma glucose levels within 
the first 72 hours of life in exclusively breast fed infants and Figure 3 shows the distribution of 
these blood glucose levels.  
 
In addition to the low blood glucose levels, the serum insulin concentrations are inappropriately 
high during this transitional phase of normal glucose physiology, suggesting a transient 
alteration in the set point for insulin secretion during this period [24, 25]. However, despite the 
marked variability in the blood glucose levels and transient alteration in the set point for insulin 
secretion during the first few hours of life, after about 72 hours of age, all term healthy newborns 
reach fasting blood glucose levels comparable to those of children and adults (3.5-5.5mmol/L). 
The above endocrine and metabolic profiles observed in appropriate for gestational age normal 
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infants in the first a few days of life suggest that these are relatively low blood glucose levels in 
comparison to older babies where the glucose set point for suppression of insulin secretion is 
reduced[25].  
 
The drop in the glucose levels noted after birth appears essential to facilitate physiological 
transition for neonatal survival, which includes increased glucose production by glycogenolysis, 
gluconeogenesis, stimulation of appetite, adaptation to fast/feed cycles, and promotion of 
oxidative fat metabolism using lipid from fat stores and ingested milk feeds[26]. The trigger for 
the metabolic and endocrine adaptation with reference to glucose control is unclear, but surges 
in catecholamines and glucagon secretion are thought to be important. The raised plasma 
insulin to glucagon ratio is reversed at birth allowing glucagon to activate adenylate cyclase and 
increase the activity of cAMP-dependent protein kinase A (PKA). This in turn, activates 
phosphorylase kinase which facilitates glucose release into the circulation. 
  
The catecholamine surge and an increase in TSH (thyroid stimulating hormone) activates 
lipolysis and lipid oxidation, resulting in increases in the levels of glycerol and free fatty 
acids[27].  Free fatty acids are transported to the liver to generate ketone bodies which are used 
as an alternative source of fuel. Major changes occur in the function of several physiological 
systems after birth which enables the neonate to adapt to postnatal nutrition. Successful enteral 
feeding in healthy term newborns triggers the secretion of gut peptides and plays a key role in 
triggering a cascade of developmental changes in gut structure and function, and in the relation 
of pancreatic endocrine secretion to intermediary metabolism[28]. 
 
Hence, full-term infants are functionally and metabolically programmed to make the transition 
from their intrauterine dependent environment to their extra-uterine existence without the need 
for metabolic monitoring or interference with the natural breastfeeding process.  This complex 
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metabolic and endocrine adaptation process is incomplete and compromised when the infant is 
born prematurely or following intrauterine growth retardation. 
 
Maintenance of a normal blood glucose level: Integration of the physiological 
changes associated with feeding and fasting. 
Normal fasting blood glucose levels in infants, children and adults are maintained within a 
narrow range (3.5-5.5mmol/L) despite the frequent feed and fasting cycles. Insulin plays a major 
role in regulating glucose production and utilization during both the fed and fasted state. 
Following the ingestion of a meal, the plasma glucose concentration starts to increase within 15 
minutes[29]. This increase in the plasma glucose level and the stimuli from neurogenic and 
entero-insular axis (gastric inhibitory peptide (GIP) and glucagon-like peptide 1 (GLP-1)) 
stimulates insulin secretion from the pancreatic beta-cells.  Peak levels of plasma glucose are 
reached around 30-60 minutes following ingestion after which it starts to decrease until 
absorption is complete, usually about 4-5 hours later, with plasma insulin concentrations 
following a similar time course.   
 
Following the ingestion of a meal, there is a marked suppression of endogenous glucose 
production from the liver, the magnitude of which is largely determined by the insulin and 
glucagon responses[30]. Endogenous glucose production may be suppressed up to 50-60% 
with about 25 grams less glucose being delivered into the systemic circulation[31].  
 
Postprandially, plasma glucose levels are determined by a balance between the rates of 
glucose removal from the systemic circulation and the rate of delivery of glucose into the 
systemic circulation.  Also, postprandially the processes of glycogenolysis, gluconeogenesis, 
lipolysis and ketogenesis are all suppressed.  The tissues mainly responsible for the removal of 
glucose from the systemic circulation include the liver, small intestine, brain, muscle and 
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adipose tissue. The magnitude of glucose uptake by the tissues, except for the brain, is largely 
determined by the plasma insulin concentration.  Glucose uptake by the brain is determined by 
the plasma glucose concentration and is independent of the plasma insulin concentration.   
 
The 4-6 hours interval following the ingestion of a meal is sometimes referred to as the post 
absorptive state. During this interval, a steady state is reached whereby glucose production is 
equal to the rate of glucose consumption and plasma glucose concentrations are maintained 
within a normal range. During this state, it is estimated that glucose turnover (glucose 
production and utilization) is approximately 10micromol/kg/min[32]. In this state, non-insulin 
dependent utilization of glucose accounts for 80%, mainly by the brain (which accounts for 50% 
of the total), red blood cells, kidneys and the gastro-intestinal system. During this phase, 
glucose concentrations are maintained by interactions between insulin and the various counter-
regulatory hormones including glucagon, cortisol, GH, adrenaline and nor-adrenaline. Glucagon 
allows the controlled release of stored glycogen from the liver and insulin restrains the effects of 
glucagon by preventing accelerated lipolysis and proteolysis.  The counter-regulatory hormones 
including cortisol and GH play permissive roles in setting the sensitivity of the peripheral tissues 
to glucagon and insulin.  
 
As the period of the fast is lengthened, utilization of glucose by the tissues decreases while 
utilization of free fatty acids and ketone bodies increases[33].  There is a reduction in hepatic 
glucose output, which is accounted for mainly by a decrease in glycogenolysis, with an increase 
in the rate of gluconeogenesis. The increased gluconeogenesis is thought to be related to the 
increased secretion of glucagon and other counter-regulatory hormones, as well as the 
reduction in insulin secretion.  The increased glucagon secretion is associated with reduced 
insulin secretion allowing stored fats to be converted to glycerol and fatty acids and proteins to 
be converted to amino acids for gluconeogenesis.  The liberated free fatty acids are transported 
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to the liver bound to albumin, where they can either undergo beta-oxidation in the mitochondria 
or be re-esterified to triacylglycerol’s and phospholipids.  The process of beta-oxidation yields 
acetyl-Co which can then be converted to ketone bodies, acetoacetate and 3β-hydroxybutyrate, 
via the hydroxymethylglutaryl-CoA (HMG-CoA) pathway, or it can undergo complete oxidation in 
the tricarboxylic acid cycle.  
 
The major gluconeogenic precursors after an overnight fast are lactate, glycerol and alanine.  
The majority of the lactate and alanine generated after an overnight fast originate from plasma 
glucose and represent recycling of carbon atoms.  The first reaction in gluconeogenesis 
involves the conversion of pyruvate to oxaloacetate to phosphoenolpyruvate.  The second of 
these reactions converts fructose-1, 6-biphosphate to fructose-6-biphosphate.  This is the rate-
limiting step for the process of gluconeogenesis.  The final step involves the conversion of 
glucose-6-phosphate to free glucose.  
 
Young children differ from adults in that they have limited glycogen stores which are only 
adequate for a period of starvation of approximately 12 hours after which the maintenance of a 
normal blood glucose concentration is dependent on gluconeogenesis. Haymond et al[34] 
showed that children fasted for 30 hours and had the lowest glucose and alanine concentrations 
as compared to adult men and women. For this reason, children are unable to tolerate 
prolonged periods of starvation.  
 
Children have higher glucose production rates in comparison to adults in order to meet  
the increased metabolic demands of the brain that, relative to body size, is much larger  
than in adults.  Bier et al[35] measured glucose production rates in infants and children using  
6,6-dideuteroglucose and showed that the brain size was the principal determinant of  
factors that regulate hepatic glucose output throughout life.  
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Sunehag et al[36] have shown that the rate of gluconeogenesis, on a body weight basis, is 
greater in children between the ages of 8 and 9 years than in adolescents between the ages of 
14 and 16 years, whereas the fraction of glucose production derived from gluconeogenesis was 
essentially identical between the two groups of subjects.  The same study showed that 
gluconeogenesis contributed to 50% of glucose production in the childhood period. The fasting 
newborn and young children demonstrate a high glucose utilization rate per kilogram body 
weight relative to adult requirements.  Hence for these reasons, children are more susceptible to 
hypoglycaemia in comparison to adults. 
 
Muscle and other tissues become progressively more dependent on free fatty acids and ketone 
bodies for their continued energy requirements as the period of the fast is prolonged.  Ketone 
bodies are produced in the liver, mainly from the oxidation of fatty acids, and are exported to 
peripheral tissues for use as an energy source.  They are particularly important for the brain, 
which has no other substantial non-glucose-derived energy source.  Ketone bodies replace 
glucose as the predominant fuel for nervous tissue, thereby reducing the obligatory requirement 
of the brain[37].  
 
During the period of a fast there is a complex interaction of metabolic and hormonal 
mechanisms, which produces significant variations in the concentrations of the counter-
regulatory hormones and intermediary metabolites.  Children differ in their response to fasting in 
comparison to adults[34]. For example, studies in adults have shown that the levels of free fatty 
acids, glycerol, and ketones in the blood gradually increase as the period of starvation is 
extended[38].  During a brief period of fasting in the childhood period, ketosis and ketonuria 
develop readily, suggesting that children convert more rapidly to a fuel economy based largely 
on fat. Thus infants and children develop hypoglycaemia more readily.  
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Conclusions 
Apart from the immediate neonatal period, the normal range of fasting blood glucose 
concentration is 3.5-5.5mmol/L. Blood glucose concentrations are kept within this range by a 
complex interplay of hormones which control glucose production and utilization. In term 
appropriate for age healthy newborns within the first few hours of life, “normal” blood glucose 
concentrations can range between 1.4 to 6.2mmol/L, but by about 72 hours of life they reach 
values of 3.5-5.5mmol/L. Hypoglycaemia should be considered as a continuum and the blood 
glucose concentration should be interpreted in the context of the clinical presentation, counter-
regulatory hormonal responses and in relation to the intermediate metabolites.  
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Legends 
Figure 1: The metabolic, endocrine and the physiological changes which occur at the time of 
birth to allow a normal term newborn to adapt to an independent existence.       
 
Table 1: Studies that have published “normal” blood glucose concentrations (BM) in healthy, 
appropriate for gestational age (AGA) newborns in the first hours of life. 
 
Figure 2: Plasma glucose concentrations measured serially in 200 term appropriate size for 
gestational age and exclusively breast-fed infants, at 3, 6, 24 and 72 hours of age (adapted 
from[23]). 
 
Figure 3: Plasma glucose concentration distribution at the time of sampling in 200 term 
appropriate size for gestational age and exclusively breast-fed infants, at 3, 6, 24 and 72 hours 
of age (adapted from[23]).  
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Table 1 
 
BM: Blood glucose concentration. AGA: Appropriate size for gestational age. NVD: Normal vaginal delivery. C-section: Caesarean section. NICU: 
Neonatal intensive care unit.  
¥ When available       
*Whole blood values reported using Nova Stat were adjusted to plasma glucose values using a correction factor of 1.135 
Publication 
Author, year 
[Reference] 
Study size (n) 
Age (hours 
of life) 
BM in mmol/l, 
Mean ± SD¥ 
(range)¥ 
Feeding mode when 
sampled 
Subjects’ characteristics 
Study design 
Method of analysis 
Acharya and Payne, 
1965 (19) 
14 0 
4.0 ± 0.9 
(2.5-5.3) 
Not specified 
Term, AGA,  no maternal or 
neonatal complications 
Not specified 
 
 
 
Nelson-Somogyi 
photometric assay [assay also 
measures other reducing sugars] 
14 1 
3.5 ± 1.1 
(1.7-5.9) 
14 2 
3.3 ± 1.0 
(1.7-5.2) 
14 3 
3.5 ± 1.1 
(2.2-6.2) 
14 5 
3.5 ± 1.2 
(2.2-5.4) 
14 7 
3.3 ± 1.1 
(1.9-4.9) 
14 9 
3.3 ± 0.8 
(1.8-4.9) 
14 11 
3.6 ± 1.5 
(2.3-7.9) 
14 18 
3.5 ± 0.9 
(2.3-5.8) 
14 24 
3.2 ± 0.8 
(1.6-4.3) 
14 36 
3.1 ± 0.9 
(1.6-5.0) 
14 48 
3.3 ± 0.7 
(2.2-5.0) 
Srinivasan et al, 
1986 (20) 
52 1 
3.11 ± 1.06 
(0.9–6.6) 
Not fed 
Full term, AGA (2.5-4.0Kg), no 
maternal or neonatal 
complications 
Longitudinal 
 
Beckman glucose oxidase analyzer 
52 2 
3.33 ± 0.61 
(2.17-5.33) 
51 3 
3.89 ± 0.72 
(2.2-5.4) 
Heck and Erenberg, 
1987 (21) 
113 1 3.33 ± 1.00 
Not fed 
Term (37 – 42 weeks), no 
maternal or neonatal 
complications 
Longitudinal 
Beckman glucose oxidase analyzer 
107 2 3.39 ± 0.83 
Hawdon et al, 1992 
(17) 
9 NVD 0 4.3 
Breast or formula 
Term (>37 weeks), AGA, white 
ethnicity, born by NVD or C-
section, no maternal or 
neonatal complications 
Cross-sectional 
 
Cobas fast centrifugal 
analyser 
24 C-section 0 3.4 
11 NVD 1-12 3.1 
11 C-section 1-12 3.3 
9 NVD 12-24 3.7 
10 C-section 12-24 3.3 
27 Day 2 3.5 
27 Day 3 3.4 
21 Day 4 4.1 
20 Day 5 4.0 
20 Day 6 4.2 
Sweet et al, 1999 (18) 
22 1 2.34 ± 0.91 Breast 
Babies >37 weeks, normal 
Apgars, not admitted to NICU, 
no maternal diabetes 
Cross-sectional 
 
HemoCue B-Glucose system 
24 1 2.52 ± 0.84 Formula 
29 1 2.58 ± 0.94 Not fed 
Hoseth et al, 
2000 (16)  
22 1 
2.9 ± 0.7 
(1.4-4.0) 
Breast 
Term (37 – 42 weeks), AGA, 
normal Apgars,  no maternal 
or neonatal complications 
Cross-sectional 
Glucose dehydrogenase 
photometric 
method 
27 2 
3.2 ± 0.8 
(2.0-4.9) 
Dollberg et al, 2001 
(22) 
50 2-4 
3.97±0.76* 
(1.8-5.8) 
Not specified 
Term (38 – 41 weeks), AGA, 
normal Apgars,  no maternal 
or neonatal complications 
Cross-sectional 
Nova Stat 
Profile M glucose oxidase electrode 
Diwakar and Sasidhar, 
2002 (23) 
200 
3 
3.0 ± 1.05 
(1.4-8.3) 
Fed and not fed 
Term (37 – 42 weeks),  AGA, 
normal Apgars,  no maternal 
or neonatal complications 
Longitudinal 
Hitachi 902 Nova Biomedical Corp 
6 
2.95 ± 0.75 
(1.6-5.4) 
24 
2.89 ± 0.79 
(1.3-7.6) 
72 
3.0 ± 0.79 
(1.4 – 7.1) 
 23 
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Figure 3 
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